MUHAREB MUSTAFA

Allopathic & Osteopathic Physicians|Family Medicine GAINESVILLE, GA NPI 1114554458

General Payments — all program years on this page

$133.99

  • Category: General Payments
  • Program years: PY2022–2023
  • Record count: 2
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $14.00 across 1 record · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $14.001

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $14.001

By program year

Program yearAmountRecords
2022 $119.991
2023 $14.001

Records — PY2023 (1)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1025061597 AstraZeneca Pharmaceuticals LP $14.00 02/23/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.